tiprankstipranks
Trending News
More News >
Kaken Pharmaceutical Co (JP:4521)
:4521
Japanese Market

Kaken Pharmaceutical Co (4521) Ratios

Compare
0 Followers

Kaken Pharmaceutical Co Ratios

JP:4521's free cash flow for Q3 2025 was ¥0.61. For the 2025 fiscal year, JP:4521's free cash flow was decreased by ¥ and operating cash flow was ¥0.24. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
5.27 5.62 5.27 5.81 5.34
Quick Ratio
4.53 4.72 4.53 5.02 4.63
Cash Ratio
2.86 2.66 2.86 3.20 2.99
Solvency Ratio
0.27 0.39 0.27 0.45 0.58
Operating Cash Flow Ratio
0.44 0.14 0.44 0.70 0.68
Short-Term Operating Cash Flow Coverage
2.40 0.67 2.40 3.46 3.74
Net Current Asset Value
¥ 80.41B¥ 79.11B¥ 80.41B¥ 83.75B¥ 86.59B
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.02 0.02 0.02 0.02
Debt-to-Equity Ratio
0.03 0.03 0.03 0.03 0.03
Debt-to-Capital Ratio
0.03 0.03 0.03 0.03 0.03
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.22 1.19 1.22 1.20 1.20
Debt Service Coverage Ratio
2.38 2.79 2.38 3.12 3.84
Interest Coverage Ratio
470.47 559.59 470.47 1.00K 1.05K
Debt to Market Cap
0.03 0.03 0.03 0.03 0.02
Interest Debt Per Share
102.93 102.47 102.93 101.82 100.21
Net Debt to EBITDA
-5.27 -3.72 -5.27 -3.49 -2.98
Profitability Margins
Gross Profit Margin
54.20%53.49%54.20%54.68%54.56%
EBIT Margin
9.36%13.62%9.36%18.29%24.91%
EBITDA Margin
14.48%17.45%14.48%21.55%26.82%
Operating Profit Margin
10.96%13.20%10.96%22.44%23.72%
Pretax Profit Margin
9.34%13.60%9.34%18.26%24.88%
Net Profit Margin
7.45%11.14%7.45%12.56%17.88%
Continuous Operations Profit Margin
7.45%11.14%7.45%12.56%17.88%
Net Income Per EBT
79.80%81.92%79.80%68.77%71.85%
EBT Per EBIT
85.23%102.97%85.23%81.37%104.89%
Return on Assets (ROA)
3.27%4.68%3.27%5.78%8.21%
Return on Equity (ROE)
3.99%5.58%3.99%6.93%9.84%
Return on Capital Employed (ROCE)
5.50%6.23%5.50%11.68%12.52%
Return on Invested Capital (ROIC)
4.27%5.04%4.27%7.82%8.76%
Return on Tangible Assets
3.41%4.89%3.41%6.08%8.24%
Earnings Yield
3.92%6.13%3.92%6.46%8.01%
Efficiency Ratios
Receivables Turnover
3.79 3.03 3.79 3.75 3.65
Payables Turnover
5.38 4.72 5.38 5.80 3.98
Inventory Turnover
2.15 1.95 2.15 2.30 2.24
Fixed Asset Turnover
2.86 2.84 2.86 2.95 3.00
Asset Turnover
0.44 0.42 0.44 0.46 0.46
Working Capital Turnover Ratio
0.81 0.81 0.81 0.83 0.84
Cash Conversion Cycle
198.39 229.98 198.39 193.03 171.03
Days of Sales Outstanding
96.36 120.30 96.36 97.26 100.03
Days of Inventory Outstanding
169.93 187.02 169.93 158.68 162.79
Days of Payables Outstanding
67.91 77.34 67.91 62.91 91.79
Operating Cycle
266.29 307.31 266.29 255.94 262.83
Cash Flow Ratios
Operating Cash Flow Per Share
246.28 68.29 246.28 351.15 372.64
Free Cash Flow Per Share
187.56 10.86 187.56 265.39 313.40
CapEx Per Share
58.72 57.42 58.72 85.76 59.24
Free Cash Flow to Operating Cash Flow
0.76 0.16 0.76 0.76 0.84
Dividend Paid and CapEx Coverage Ratio
1.18 0.33 1.18 1.49 1.78
Capital Expenditure Coverage Ratio
4.19 1.19 4.19 4.09 6.29
Operating Cash Flow Coverage Ratio
2.40 0.67 2.40 3.46 3.74
Operating Cash Flow to Sales Ratio
0.13 0.04 0.13 0.18 0.19
Free Cash Flow Yield
5.08%0.31%5.08%6.82%7.23%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
25.52 16.30 25.52 15.47 12.48
Price-to-Sales (P/S) Ratio
1.90 1.82 1.90 1.94 2.23
Price-to-Book (P/B) Ratio
1.02 0.91 1.02 1.07 1.23
Price-to-Free Cash Flow (P/FCF) Ratio
19.70 319.11 19.70 14.66 13.83
Price-to-Operating Cash Flow Ratio
15.00 50.77 15.00 11.08 11.63
Price-to-Earnings Growth (PEG) Ratio
-0.60 0.35 -0.60 -0.56 -0.42
Price-to-Fair Value
1.02 0.91 1.02 1.07 1.23
Enterprise Value Multiple
7.86 6.69 7.86 5.53 5.34
Enterprise Value
83.11B 84.06B 83.11B 90.56B 107.43B
EV to EBITDA
7.86 6.69 7.86 5.53 5.34
EV to Sales
1.14 1.17 1.14 1.19 1.43
EV to Free Cash Flow
11.79 205.02 11.79 8.98 8.88
EV to Operating Cash Flow
8.98 32.62 8.98 6.79 7.47
Tangible Book Value Per Share
3.46K 3.61K 3.46K 3.43K 3.51K
Shareholders’ Equity Per Share
3.63K 3.81K 3.63K 3.63K 3.53K
Tax and Other Ratios
Effective Tax Rate
0.20 0.18 0.20 0.31 0.28
Revenue Per Share
1.94K 1.91K 1.94K 2.00K 1.94K
Net Income Per Share
144.79 212.66 144.79 251.44 347.37
Tax Burden
0.80 0.82 0.80 0.69 0.72
Interest Burden
1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.22 0.17 0.22 0.11 0.09
SG&A to Revenue
0.00 <0.01 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.36 0.32 1.36 0.96 0.77
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis